Driven by the rapid increase of biologic therapies in development, advanced techniques in quantitative analysis of protein therapeutics and biomarkers by LC-MS now allow unprecedented levels of sensitivity, selectivity, precision, and accuracy. Two such approaches are high resolution accurate mass spectrometry (HRMS) and hybrid immunoaffinity liquid chromatography-mass spectrometry (IA-LC-MS).
IQVIA Laboratories is a pioneer in helping drive advances in the bioanalysis of protein-based drugs and biomarkers. Download this insight brief to learn how we continue to incorporate advanced techniques and technologies, such as HRMS, IA-LC-MS, and low-flow chromatography and ionization, into our methodologies to optimize our customers' drug development outcomes.
Complete the form below to access this insight brief
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)
Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
High Throughput ADME Testing
Minimizing turnaround time for ADME assays
Bioanalytical & ADME Laboratory Services
Accelerate and enhance your discovery, preclinical and clinical programs
ADME Services
Accelerating your drug discovery, preclinical and clinical programs with ADME services
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
Early Hit-to-Lead ADME Screening Bundle
Bundled Screening Assays to Accelerate Candidate Selection in Drug Discovery
